Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Biofrontera (BFRIW) Non Operating Investment Income (2022 - 2025)

Biofrontera has reported Non Operating Investment Income over the past 4 years, most recently at -$1000.0 for Q4 2025.

  • Quarterly results put Non Operating Investment Income at -$1000.0 for Q4 2025, up 50.0% from a year ago — trailing twelve months through Sep 2025 was -$1000.0 (up 99.87% YoY), and the annual figure for FY2025 was $2000.0, up 114.29%.
  • Non Operating Investment Income for Q4 2025 was -$1000.0 at Biofrontera, down from $1000.0 in the prior quarter.
  • Over the last five years, Non Operating Investment Income for BFRIW hit a ceiling of $1.7 million in Q4 2022 and a floor of -$2.9 million in Q1 2023.
  • Median Non Operating Investment Income over the past 4 years was -$2000.0 (2024), compared with a mean of -$473916.7.
  • Biggest five-year swings in Non Operating Investment Income: crashed 144.99% in 2023 and later surged 150.0% in 2025.
  • Biofrontera's Non Operating Investment Income stood at $1.7 million in 2022, then tumbled by 144.99% to -$786000.0 in 2023, then skyrocketed by 99.75% to -$2000.0 in 2024, then soared by 50.0% to -$1000.0 in 2025.
  • The last three reported values for Non Operating Investment Income were -$1000.0 (Q4 2025), $1000.0 (Q3 2025), and $2000.0 (Q2 2025) per Business Quant data.